|
AU2015268617A1
|
|
Method for breast cancer recurrence prediction under endocrine treatment
|
|
AU2015217698A1
|
|
Method for predicting the response and survival from chemotherapy in patients with breast cancer
|
|
EP2951317A1
|
|
Method for predicting the benefit from inclusion of taxane in a chemotherapy regimen in patients with breast cancer
|
|
HUE032391T2
|
|
Method for predicting the response to chemotherapy in a patient suffering from or at risk of developing recurrent breast cancer
|
|
CA2793133A1
|
|
Method for breast cancer recurrence prediction under endocrine treatment
|
|
EP2344971A1
|
|
Method for the quality assessment of nucleic acid amplification reactions
|
|
EP2304630A1
|
|
Molecular markers for cancer prognosis
|
|
EP2048241A1
|
|
Method employing GAPDH as molecular markers for cancer prognosis
|
|
EP2066805A2
|
|
Methods for breast cancer prognosis
|
|
EP1954830A1
|
|
Methods and kits for breast cancer prognosis
|
